Legal & General Group’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.54M Buy
75,391
+8,808
+13% +$414K ﹤0.01% 1703
2025
Q1
$2.94M Buy
66,583
+818
+1% +$36.1K ﹤0.01% 1775
2024
Q4
$2.38M Buy
65,765
+6,468
+11% +$234K ﹤0.01% 1904
2024
Q3
$1.9M Buy
59,297
+1,199
+2% +$38.4K ﹤0.01% 1995
2024
Q2
$2.19M Buy
58,098
+7,285
+14% +$274K ﹤0.01% 1907
2024
Q1
$2.5M Buy
50,813
+1,144
+2% +$56.3K ﹤0.01% 1836
2023
Q4
$1.81M Buy
49,669
+12,055
+32% +$440K ﹤0.01% 1996
2023
Q3
$870K Sell
37,614
-437
-1% -$10.1K ﹤0.01% 2233
2023
Q2
$998K Buy
38,051
+4,240
+13% +$111K ﹤0.01% 2227
2023
Q1
$870K Buy
33,811
+9,190
+37% +$237K ﹤0.01% 2183
2022
Q4
$640K Sell
24,621
-2,274
-8% -$59.1K ﹤0.01% 2276
2022
Q3
$767K Sell
26,895
-1,534
-5% -$43.7K ﹤0.01% 2227
2022
Q2
$700K Buy
28,429
+6,660
+31% +$164K ﹤0.01% 2264
2022
Q1
$1.23M Buy
21,769
+3
+0% +$169 ﹤0.01% 2166
2021
Q4
$1.35M Buy
21,766
+51
+0.2% +$3.16K ﹤0.01% 2164
2021
Q3
$1.38M Buy
21,715
+3,829
+21% +$243K ﹤0.01% 2157
2021
Q2
$1.47M Buy
17,886
+3,720
+26% +$307K ﹤0.01% 2099
2021
Q1
$1.04M Buy
14,166
+10,635
+301% +$783K ﹤0.01% 2181
2020
Q4
$256K Buy
3,531
+418
+13% +$30.3K ﹤0.01% 2371
2020
Q3
$148K Sell
3,113
-936
-23% -$44.5K ﹤0.01% 2410
2020
Q2
$170K Buy
4,049
+2,508
+163% +$105K ﹤0.01% 2394
2020
Q1
$41K Sell
1,541
-23,330
-94% -$621K ﹤0.01% 2668
2019
Q4
$954K Buy
24,871
+24,676
+12,654% +$947K ﹤0.01% 2078
2019
Q3
$4K Buy
+195
New +$4K ﹤0.01% 3335